Background-Circulating levels of soluble intercellular adhesion molecule-1, soluble P-selectin, and soluble E-selectin have been associated with variation at the ABO locus. To evaluate these associations and the effect sizes, we performed a meta-analysis with new and previous reported data for polymorphism rs579459. Methods and Results-Compared with major allele homozygotes, heterozygotes and minor allele homozygotes had 4.6% (95% CI, 3.4%-5.8%, Pϭ7.3ϫ10 Ϫ14 ) and 7.2% (95% CI, 4.7%-9.7%, Pϭ1.5ϫ10 Ϫ8 ), respectively, lower soluble intercellular adhesion molecule-1 levels (nϭ33 671). An allele dose-dependent association also was observed for soluble P-selectin (nϭ4921) with heterozygotes and minor allele homozygotes having 11.5% (95% CI, 7.2%-15.8%, Pϭ1.7ϫ10 Ϫ7 ) and 18.6% (95% CI, 9.1%-28.1%, Pϭ1.2ϫ10 Ϫ4 ), respectively, lower levels than in major allele homozygotes. A larger effect size, again consistent with an additive genetic model, was seen for soluble E-selectin (nϭ2860) whose level was 25.6% (95% CI, 19.0%-32.2%, Pϭ2.1ϫ10 Ϫ14 ) lower in heterozygotes and 43.3% (95% CI, 36.9%-49.3%, Pϭ4.3ϫ10 Ϫ42 ) lower in minor allele homozygotes than in major allele homozygotes. Conclusions-The data support the association of variation at the ABO locus with soluble intercellular adhesion molecule-1, soluble P-selectin, and soluble E-selectin levels. (Circ Cardiovasc Genet. 2011;4:681-686.)
L eukocyte recruitment plays an important role in inflammatory diseases. 1 It typically begins with leukocyte rolling on the endothelium followed by leukocyte attachment to endothelial cells and subsequently transendothelial migration. Rolling involves the interaction of leukocytes with P-selectin and E-selectin on endothelial cells, whereas leukocyte attachment to endothelial cells is mediated by intercel-lular adhesion molecule-1 and vascular cell adhesion molecule-1. 1
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Blood contains soluble forms of intercellular adhesion molecule-1 (sICAM-1), P-selectin (sP-selectin), and E-selectin (sE-selectin) generated by shedding of ectodo-mains of the membrane-bound forms of these molecules or produced from transcript variants lacking the transmembrane domain. 2 Increased circulating levels of sICAM-1, sPselectin, and/or sE-selectin have been associated with a number of diseases such as coronary heart disease and diabetes. [3] [4] [5] [6] [7] The levels of sICAM-1, sP-selectin, and sEselectin are under genetic influences with heritability estimates being 0.24 to 0.63, 0.45 to 0.70, and 0.50 to 0.64, respectively. 8 -10 Genomewide association studies of sICAM-1, sP-selectin, and sE-selectin levels have shown that they are associated with single nucleotide polymorphisms (SNPs) at the ABO locus. [11] [12] [13] [14] Interestingly, genomewide association studies of coronary heart disease (CHD) have revealed an association between CHD and variation at the ABO locus. 15, 16 To more robustly evaluate the associations of sICAM-1, sP-selectin, and sE-selectin with the ABO locus, and more reliably estimate the effect sizes, we performed a meta-analysis. We included new data from the Bruneck Study, data from several reported studies, [11] [12] [13] [14] and additional data from 1 of these reported studies. 11
Methods
To identify association studies of SNPs at the ABO locus in relation to levels of sICAM-1, sP-selectin, and/or sE-selectin, we performed systematic searches of PubMed, scanned the reference lists of original reports, and communicated with authors of the included studies. The electronic searches combined search terms related to polymorphisms at the ABO locus (eg, ABO, polymorphism, SNP, variation, and variant) and intercellular adhesion molecule-1, P-selectin, or E-selectin. The searches identified 4 publications. In 2 of these publications, 12, 13 SNP rs579459 showed the strongest association with sP-selectin or sE-selectin levels among all tested SNPs at the ABO locus. In another study (in which rs579459 was not directly typed), 11 SNP rs507666 had the most significant association with sICAM-1 levels among all tested SNPs at this locus. In the fourth study (which also did not type rs579459 directly), 14 SNP rs651007 was the top SNP at the ABO locus associated with sICAM-1 and sE-selectin levels. An analysis using the SNAP program (www.broadinstitute.org/mpg/snap/) with data from the 1000 Genomes Project showed that rs579459 was in perfect linkage disequilibrium with rs651007 and in near perfect linkage disequilibrium (r 2 ϭ0.96) with rs507666 in individuals of European ancestry.
We genotyped the Bruneck cohort 17 for SNP rs579459 using the KASPar method. sICAM-1, sP-selectin, and sE-selectin levels in the Bruneck cohort had been measured by an enzyme-linked immunosorbent assay as described previously. 17, 18 The Bruneck Study was approved by the local ethics committee and all participants gave their written informed consent.
We performed a meta-analysis with data from the Bruneck cohort and the 4 reported studies [11] [12] [13] [14] as well as additional data from 1 of these reported studies, the Women's Genome Health Study (WGHS) study 11 for which ethic approval was granted by the Institutional Review Board. For the meta-analysis, we only used summary statistic data from the cohorts and did not receive individual participant data. The meta-analysis included 7 data sets for sICAM-1, 4 for sP-selectin, and 4 for sE-selectin. For the meta-analysis, data of unadjusted mean and SD of sICAM-1, sP-selectin, and sE-selectin levels according to genotypes were provided by authors of 3 of the previous studies 11, 12, 14 in which this information was not available in the articles and were extracted from the report of the other study. 13 With the use of the StatsDirect and Comprehensive Meta Analysis Version 2.0 software, we performed meta-analysis of weighted mean difference in the percentage of and the unbiased 19 Consistency of findings across studies was assessed by the I 2 statistic. 20 Evidence of publication bias was assessed using funnel plots and the Egger test. 21 Possible reasons for heterogeneity were investigated by metaregression analysis.
Results and Discussion
The characteristics of study subjects are summarized in the Table. A total of 33 671 subjects were available for the meta-analysis of sICAM-1, 4921 for sP-selectin, and 2860 for sE-selectin.
The meta-analysis showed that sICAM-1 levels were 4.6% (95% CI, 3.4%-5.8%) lower in heterozygotes and 7.2% (4.7%-9.7%) lower in minor allele homozygotes than in major allele homozygotes (Pϭ7.3ϫ10 Ϫ14 and Pϭ1.5ϫ10 Ϫ8 ; Figure A) . Similarly, an allele dose-dependent association was observed for sP-selectin with heterozygotes and minor allele homozygotes having 11.5% (7.2%-15.8%) and 18.6% (9.1%-28.1%), respectively, lower levels than in major allele homozygotes (Pϭ1.7ϫ10 Ϫ7 and Pϭ1.2ϫ10 Ϫ4 ; Figure B ). An allele dose-dependent association also was seen for Table I ) which a metaregression analysis indicated was not attributed to differences among individual studies in age, sex, type of subjects (population-based or diabetics), number of subjects (Ͼ1000 or Ͻ1000), type of blood sample used (plasma or serum), or which SNP studied, although the metaregression analysis had low power due to the relatively small numbers of individual studies. There was no evidence of publication bias. We observed correlations among sICAM-1, sP-selectin, and sE-selectin levels (Supplemental Table II ). SNP rs507666 is located within the ABO gene, and SNP rs579459 and rs651007 are in its proximity. The ABO gene encodes a glycosyltransferase that transfers sugar residues to the H antigen and determines the ABO blood group. 22 Group A has 3 subtypes, that is, A1 and A2, respectively. It has been shown that the A1 subtype has Ͼ30-fold higher transferase activity than the A2 subtype. 23 The A1 allele is perfectly tagged by the minor allele of SNP rs507666. 11 SNP rs507666 is in near perfect linkage disequilibrium (r 2 ϭ0.96) with rs579459 and rs651007. Thus, the associations of these SNPs with sICAM-1, sP-selectin, and sE-selectin levels may represent an effect of the ABO group A1 subtype. It has been suggested that the increased glycosyltransferase activity in individuals carrying the A1 allele might have an effect on the shedding, clearance, or secretion of adhesion molecules, thereby influencing their levels in the circulation. 11, 12 Adhesion molecules are crucial to platelet leukocyte interaction and leukocyte migration into the vessel wall and thus important players in the atherosclerosis process underlying CHD. 2, 24 In a number of previous studies, increased CHD risk has been associated with high sICAM-1, sP-selectin, and sE-selectin levels. 3, 5, 6 Unexpectedly, variants at the ABO locus conferring elevated CHD risk, 15, 16, 25 like the minor allele of SNP rs579459, 16 were associated with decreased levels of soluble adhesion molecules in our meta-analysis. One possible explanation for this seeming paradox may be that soluble adhesion molecules, although elevated in the case of endothelial dysfunction, actually compete with leukocyte adhesion to the endothelium (competition to cell surface adhesion molecules). Another possibility may be that the lower levels of soluble adhesion molecules might arise because of lower shedding of ectodomains, potentially leaving higher levels of intact cell surface adhesion molecules to recruit leukocytes to the blood vessel wall. To date, it is not known whether elevated levels of soluble adhesion molecules in vascular high-risk patients represent an epiphenomenon of vessel wall pathology, a true risk factor, or a counterregulatory per se protective mechanism as indicated by preliminary experimental data. 16 Experimental studies are required to further elaborate the pathophysiological role of soluble adhesion molecules and to clarify whether the prominent alterations in sICAM-1, sP-selectin, and sEselectin observed in this study are relevant to the recently discovered association between ABO SNPs and CHD risk.
Some limitations to our study warrant mentioning. First, the mechanism underlying the association of SNPs at the ABO locus with sICAM-1, sP-selectin, and sE-selectin levels has remained unclear. Second, because SNP rs579459 is in strong linkage disequilibrium with a number of other SNPs at this locus, it remains unknown which SNP is the causal variant. Third, because this study was conducted in individuals of European ancestry, the findings may not be generalizable to other races/ethnicities.
In conclusion, our study provides compelling evidence of an allele dose-dependent association of variation at the ABO locus with circulating sICAM-1, sP-selectin, and sE-selectin levels. These results contribute to the knowledge of genetic influences on these adhesion molecules, which play important roles in many inflammatory diseases. 
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